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ABSTRACT 
The aim of our study was to examine the short term effect ofdisulfiram on pulmonary functions 
of alcohol dependent subjects, who were chronic smokers J/Ve compared FEV1 % values on spirometry 
and airway reactivity to histamine challenge in alcohol dependent subjects at baseline and after 2 
weeks of treatment with disulfiram. Disulfiram did not significantly alter FEVI values and airway 
reactivity during the treatment period and can thus be used safely in alcohol dependent subjects who 
are current smokers. 
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Disulfiram is effective in the treatment of 
alcohol dependence syndrome, especially, when 
given under supervision (Azrain, eta!.,1992; Chick 
et al.,1992; Fuller, 1995). However the use of 
Disulfiram in the treatment of alcohol dependence 
syndrome is restricted by the presence of 
comorbid psychiatric and medical conditions like 
depression, psychosis, hepatitis and uncontrolled 
hypertension (Rossiter,1992; Mason, 1989; Lake 
etal., 1977). It is also recommended that disulfiram 
should be used with caution in the presence of 
respiratory disorders (Thorley, 1982) especially, in 
view of bronchospasm during a Disulfiram Ethanol 
reaction (Zapata & Orwin,1992). Alcohol was also 
found to be a significant independent predictor of 
decline in forced expiratory volume (FEV1) (Lange 
et al.,1980). In addition, disu'ifiram has several 
toxic metabolites of which carbon disulphide (CS2) 
is mainly excreted through the lungs 
(Stromme,1965). Since there is a high prevalence 
of smoking and chronic obstructive pulmonary 
diseases among patients with alcohol dependence 
(Heinemann,1977; Burch & Depasquale, 1967., 
Srinivasan & Augustine,2000), we planned to 
study the effect of disulfiram on pulmonary 
function tests in alcohol dependent subjects. 
The aim of the present study was to 
examine the effect of disulfiram on lung function 
spirometry and bronchial responsiveness to 
histamine in alcohol dependent subjects who were 
also chronic smokers. 
MATERIAL AND METHODS 
Subiects:The subjects were recruited from alcohol 
detoxification and inpatient treatment programme 
at the department of psychiatry, St. John's 
Medical College Hospital, Bangalore. This study 
was approved by the ethics committee of St. John's 
Medical College Hospital. 
Male patients admitted and diagnosed to 
have alcohol dependence according to 
International Classification of Diseases (ICD)-
version 10 (WHO, 1992), with a history of chronic 
smoking and cough and willing to take disulfiram 
were included as subjects for the study after 
obtaining informed consent Those patients who 
had severe asthma and recent respiratory infection 
were excluded. Patients on antihistaminic drugs, 
steroids and bronchodilators were also not 
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included in the study. 
Clinical assessment: The patients entered the 
study after the remission of alcohol withdrawal 
symptoms. The details regarding smoking, 
respiratory symptoms, intake of any concomitant 
medications, atopy and occupational dust 
exposure were noted. The alcohol history was 
obtained by a clinical interview and the severity of 
alcohol dependence syndrome was assessed 
using the Short Alcohol Dependence Data (SADD) 
(Davidson & Raistrick, 1986). Total score on SADD 
were interpreted as follows: 1-9 bw dependence, 
10-19 medium dependence and 20 or greater, high 
dependence. 
Current smokers were defined as men who 
smoked 20 packs of cigarettes or more in a 
lifetime or at least 1 cigarette per day for 1 year 
and were smoking at the time of the study. Pack 
years (lifetime smoking) was calculated based on 
average daily consumption of cigarette packs 
multiplied by years of smoking. 
Disulfiram was given under supervision. In 
our centre, after obtaining an informed consent, 
patients receive 250 mg of disulfiram twice a day 
for the first four days and later are maintained on 
250 mg of disulfiram per day. Our previous 
experience suggests that 250 mg of disulfiram 
per day is an adequate dose for most of our 
patients (Srinivasan, etal.,1986). 
Pulmonary Function Tests: Spirometry was done 
in a pulmonary function lab located within the 
hospital using Sensor Medics VMax 22 system 
according to standard guidelines of American 
Thoracic Society (1995). The tests were done after 
the remission of alcohol withdrawal symptoms. 
Each subject had to perform the test thrice i.e., 
before starting disulfiram, after 4 days of treatment 
with 500mg of disulfiram and at the end of 2 weeks 
of maintenance treatment on 250 mg of disulfiram. 
The best effort FVC and FEV1 values were noted 
from three stable values on each testing occasion. 
FEV1 was standardized for subject's height. 
Histamine inhalation challenge test: Bronchial 
responsiveness was measured using histamine 
inhalation test by tidal breathing method described 
by Cockcroft et al.(1977). The histamine 
provocative test was tlone before starting 
treatment with disulfiram and repeated two weeks 
later while the patients were on a maintenance 
dose of 250mg of Disulfiram per day. Those 
patients who at baseline were positive to the 
histamine provocative test were excluded for the 
repeat challenge done after two weeks of 
treatment with disulfiram. The test was terminated 
if there was a fall of FEV1 greater than 20% from 
the post diluent FEV1 or when the maximum 
concentration of histamine reached 5mg/ml. The 
maximum dose of 5mg/ml was chosen because 
in our laboratory it defines patients with significant 
airway reactivity. Those who did not respond even 
to 5mg/ml of histamine were considered as non-
reactors. 
Data Analysis: Repeat measure ANOVA was 
used to analyse FEV1 values obtained at all 3 
spirometric pulmonary function test occasions. 
RESULTS 
27 patients were screened for the study. 
Of these 27 subjects, eight patients dropped out 
during the follow-up period. 19 patients underwent 
spirometry tests on all 3 occasions namely, at 
baseline, and after 4 days of initiating disulfiram 
therapy and 15 days later while on maintenance 
treatment. 27 patients underwent histamine 
bronchoprovocation tests at baseline of which 12 
patients were sensitive to histamine and hence 
did not undergo the second histamine provocation 
after 15 days of treatment with disulfiram. One 
patient could not undergo second histamine 
challenge because he had acute respiratory 
infection. In all 14 patients underwent histamine 
challenge test on both the test occasions. 
The mean age of the patients included in 
study was 40.66 years (± 6.50). All the subjects 
had moderate to severe alcohol dependence 
syndrome (SADD score=20.81± 6.33) and were 
current smokers (pack years 24.23± 16.17). 
There was no significant change in the 
FEV1 done at baseline (before initiating therapy 
with Disulfiram) and after 4 days and 15 days of 
treatment with disulfiram on repeat measure 
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analysis of variance ( F=0.295, p= 0.816, df=2 & 
36). Histamine bronchoprovocation tests done after 
2 weeks of treatment with disulfiram were negative 
in all the 14 patients. 
DISCUSSION 
The literature on disulfiram treatment for 
alcohol dependent subjects suggests cautious 
use of this drug in presence of chronic obstructive 
pulmonary disease (Thorley, 1982). In addition, 
bronchospasm is known to occur during a 
disulfiram ethanol reaction (Zapata & Orwin,1992). 
In this study, we tried to assess the short term 
effect of Disulfiram on pulmonary function tests in 
alcohol dependent subjects who were current 
smokers. 
During the study period no significant 
change in smoking pattern was observed among 
the subjects. Among our subjects with normal 
baseline spirometry (FEV1, over, 80%), we found 
no decline in FEV1 when assessed during the 
two weeks of therapy with disulfiram. In those with 
baseline normal airway response to histamine, 
we found no change in responsiveness pattern to 
histamine after 2 weeks of treatment with 
Disulfiram. The present study was based on a 
small unrandomised sample. There is a need for 
further placebo controlled studies to establish 
whether disulfiram is safe in alcohol dependent 
patients who have comorbid obstructive respiratory 
conditions. 
In conclusion, we found that disulfiram did 
not significantly alter pulmonary functions during 
the initial two weeks of treatment in moderate to 
severe alcohol dependant subjects who were also 
current smokers. 
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